Skip to Main Content

Paper Details

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.
JAMA Netw Open
10
2022
Hypertriglyceridemia, IPE, Icosapent Ethyl, Icosapent ethyl, Patients, Statin, WAC, cardiovascular disease, diabetes, hypertriglyceridemia, icosapent ethyl, men, participants, patient, patients, statin, statins
Author NameAffiliation
William S WeintraubMedStar Health Research Institute
Deepak L BhattBrigham and Women's Hospital Heart and Vascular Center, Harvard Medical School
Jean-Claude TardifMontreal Heart Institute, Universite de Montreal
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
  • 1 - 5

Datasets

Release 1.2